These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

354 related items for PubMed ID: 8810278

  • 1. p130CAS forms a signaling complex with the adapter protein CRKL in hematopoietic cells transformed by the BCR/ABL oncogene.
    Salgia R, Pisick E, Sattler M, Li JL, Uemura N, Wong WK, Burky SA, Hirai H, Chen LB, Griffin JD.
    J Biol Chem; 1996 Oct 11; 271(41):25198-203. PubMed ID: 8810278
    [Abstract] [Full Text] [Related]

  • 2. The BCR/ABL oncogene alters interaction of the adapter proteins CRKL and CRK with cellular proteins.
    Uemura N, Salgia R, Li JL, Pisick E, Sattler M, Griffin JD.
    Leukemia; 1997 Mar 11; 11(3):376-85. PubMed ID: 9067577
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. BCR/ABL-induced leukemogenesis causes phosphorylation of Hef1 and its association with Crkl.
    de Jong R, van Wijk A, Haataja L, Heisterkamp N, Groffen J.
    J Biol Chem; 1997 Dec 19; 272(51):32649-55. PubMed ID: 9405482
    [Abstract] [Full Text] [Related]

  • 5. The proto-oncogene product p120CBL and the adaptor proteins CRKL and c-CRK link c-ABL, p190BCR/ABL and p210BCR/ABL to the phosphatidylinositol-3' kinase pathway.
    Sattler M, Salgia R, Okuda K, Uemura N, Durstin MA, Pisick E, Xu G, Li JL, Prasad KV, Griffin JD.
    Oncogene; 1996 Feb 15; 12(4):839-46. PubMed ID: 8632906
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Crkl is complexed with tyrosine-phosphorylated Cbl in Ph-positive leukemia.
    de Jong R, ten Hoeve J, Heisterkamp N, Groffen J.
    J Biol Chem; 1995 Sep 15; 270(37):21468-71. PubMed ID: 7545163
    [Abstract] [Full Text] [Related]

  • 8. Identification of CRKL as the constitutively phosphorylated 39-kD tyrosine phosphoprotein in chronic myelogenous leukemia cells.
    Nichols GL, Raines MA, Vera JC, Lacomis L, Tempst P, Golde DW.
    Blood; 1994 Nov 01; 84(9):2912-8. PubMed ID: 7524758
    [Abstract] [Full Text] [Related]

  • 9. Differential signaling after beta1 integrin ligation is mediated through binding of CRKL to p120(CBL) and p110(HEF1).
    Sattler M, Salgia R, Shrikhande G, Verma S, Uemura N, Law SF, Golemis EA, Griffin JD.
    J Biol Chem; 1997 May 30; 272(22):14320-6. PubMed ID: 9162067
    [Abstract] [Full Text] [Related]

  • 10. p130Cas, a substrate associated with v-Src and v-Crk, localizes to focal adhesions and binds to focal adhesion kinase.
    Harte MT, Hildebrand JD, Burnham MR, Bouton AH, Parsons JT.
    J Biol Chem; 1996 Jun 07; 271(23):13649-55. PubMed ID: 8662921
    [Abstract] [Full Text] [Related]

  • 11. Physiological signals and oncogenesis mediated through Crk family adapter proteins.
    Feller SM, Posern G, Voss J, Kardinal C, Sakkab D, Zheng J, Knudsen BS.
    J Cell Physiol; 1998 Dec 07; 177(4):535-52. PubMed ID: 10092207
    [Abstract] [Full Text] [Related]

  • 12. Structural requirements for function of the Crkl adapter protein in fibroblasts and hematopoietic cells.
    Senechal K, Heaney C, Druker B, Sawyers CL.
    Mol Cell Biol; 1998 Sep 07; 18(9):5082-90. PubMed ID: 9710592
    [Abstract] [Full Text] [Related]

  • 13. Activation of the focal adhesion kinase signaling pathway by structural alterations in the carboxyl-terminal region of c-Crk II.
    Zvara A, Fajardo JE, Escalante M, Cotton G, Muir T, Kirsch KH, Birge RB.
    Oncogene; 2001 Feb 22; 20(8):951-61. PubMed ID: 11314030
    [Abstract] [Full Text] [Related]

  • 14. Tyrosine phosphorylation of murine Crkl.
    de Jong R, Haataja L, Voncken JW, Heisterkamp N, Groffen J.
    Oncogene; 1995 Oct 19; 11(8):1469-74. PubMed ID: 7478571
    [Abstract] [Full Text] [Related]

  • 15. Interactions of CBL with BCR-ABL and CRKL in BCR-ABL-transformed myeloid cells.
    Bhat A, Kolibaba K, Oda T, Ohno-Jones S, Heaney C, Druker BJ.
    J Biol Chem; 1997 Jun 27; 272(26):16170-5. PubMed ID: 9195915
    [Abstract] [Full Text] [Related]

  • 16. Introduction of p130cas signaling complex formation upon integrin-mediated cell adhesion: a role for Src family kinases.
    Vuori K, Hirai H, Aizawa S, Ruoslahti E.
    Mol Cell Biol; 1996 Jun 27; 16(6):2606-13. PubMed ID: 8649368
    [Abstract] [Full Text] [Related]

  • 17. Involvement of p130(Cas) and p105(HEF1), a novel Cas-like docking protein, in a cytoskeleton-dependent signaling pathway initiated by ligation of integrin or antigen receptor on human B cells.
    Manié SN, Beck AR, Astier A, Law SF, Canty T, Hirai H, Druker BJ, Avraham H, Haghayeghi N, Sattler M, Salgia R, Griffin JD, Golemis EA, Freedman AS.
    J Biol Chem; 1997 Feb 14; 272(7):4230-6. PubMed ID: 9020138
    [Abstract] [Full Text] [Related]

  • 18. Insulin-like growth factor I stimulates tyrosine phosphorylation of p130(Cas), focal adhesion kinase, and paxillin. Role of phosphatidylinositol 3'-kinase and formation of a p130(Cas).Crk complex.
    Casamassima A, Rozengurt E.
    J Biol Chem; 1998 Oct 02; 273(40):26149-56. PubMed ID: 9748296
    [Abstract] [Full Text] [Related]

  • 19. Tyrosine phosphorylation of CRKL in Philadelphia+ leukemia.
    ten Hoeve J, Arlinghaus RB, Guo JQ, Heisterkamp N, Groffen J.
    Blood; 1994 Sep 15; 84(6):1731-6. PubMed ID: 7521685
    [Abstract] [Full Text] [Related]

  • 20. Integrin-mediated cell adhesion promotes tyrosine phosphorylation of p130Cas, a Src homology 3-containing molecule having multiple Src homology 2-binding motifs.
    Nojima Y, Morino N, Mimura T, Hamasaki K, Furuya H, Sakai R, Sato T, Tachibana K, Morimoto C, Yazaki Y.
    J Biol Chem; 1995 Jun 23; 270(25):15398-402. PubMed ID: 7541040
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.